Pharmacological implications of the fate of noradrenaline in the artery wall.
D000818:Animals; D001158:Arteries / Q000294:innervation*; D001626:Bethanechol Compounds / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004357:Drug Synergism; D006145:Guanethidine / Q000494:pharmacology; D066298:In Vitro Techniques; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism* / Q000502:physiology
D001626:Bethanechol Compounds; D001949:Bretylium Compounds; D008729:Methoxamine; D003042:Cocaine; D009638:Norepinephrine; D006145:Guanethidine